Alto Neuroscience (ANRO) Return on Capital Employed (2024 - 2026)

Alto Neuroscience (ANRO) has 3 years of Return on Capital Employed data on file, last reported at 35.81% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 593.0% year-over-year to 35.81%; the trailing twelve-month figure through Mar 2026 stood at 35.81% (up 593.0% YoY), and the FY2025 full-year result was 39.09%, up 1712.0% from the prior year.
• Return on Capital Employed improved to 35.81% in Q1 2026, from 42.95% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 27.97% in Q2 2024 to a low of 46.24% in Q3 2025.
• A 3-year average of 38.45% and a median of 39.3% in 2024 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed sank 1683 bps in 2025 and soared 593 bps in 2026, its largest moves.
• Tracing ANRO's Return on Capital Employed over 3 years: stood at 39.3% in 2024, then fell by 9 bps to 42.95% in 2025, then rose by 17 bps to 35.81% in 2026.
• Business Quant data shows ANRO's Return on Capital Employed at 35.81% in Q1 2026, 42.95% in Q4 2025, and 46.24% in Q3 2025.